The Centers for Medicare & Medicaid Services has announced an error in calculating Clostridium difficile infection performance during the first two quarters of 2014.

This error affects hospital performance in the fiscal year 2017 Hospital Acquired Condition Reduction Program, baseline performance in the FY 2018 hospital value-based purchasing program, and measure data reported on Hospital Compare in 2015.

As a result, CMS is conducting a second review and corrections period for the FY 2017 HAC program from today through Sept. 30 to allow hospitals to review their updated C Difficile performance.

CMS also has updated the baseline period performance standard for the FY 2018 VBP program, and intends to update the archived databases of Hospital Compare to reflect corrected performance data.

For more information, see CMS’s QualityNet website.

Related News Articles

Headline
A new issue brief from AHA’s Hospitals Against Violence initiative offers proven strategies and action steps to help hospitals and health systems’ violence…
Headline
AHA urged leaders of the Senate and House Appropriations Subcommittees on Labor, Health and Human Services, and Education to give favorable funding…
Headline
The Department of Justice May 9 announced the formation of a task force focusing on competition concerns in health care. The unit, the Task Force on Health…
Headline
The Food and Drug Administration May 9 released final guidance clarifying the definition of “remanufacturing” for reusable medical devices needing…
Headline
Pediatric sepsis is "an aggressive and unrelenting adversary that knows neither geographic nor demographic bounds," writes Chris DeRienzo, M.D., AHA’s senior…
Headline
Centers for Disease Control and Prevention and state and territorial public health officials Friday met to discuss preparedness planning for bird flu after one…